Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Rhea-AI Summary

Sangamo Therapeutics (Nasdaq: SGMO) announced its participation in several upcoming investor conferences. Management will present at the Barclays Gene Editing & Gene Therapy Summit on November 15 at 10:30 a.m. Eastern Time, followed by the Stifel 2021 Virtual Healthcare Conference on the same day at 3:20 p.m. Eastern Time. Additionally, they will participate in the Jefferies London Healthcare Conference on November 16 at 8:40 a.m. Eastern Time. Presentations will be webcasted live and available later on Sangamo's website.

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

• Barclays Gene Editing & Gene Therapy Summit
  Date: Monday, November 15^th at 10:30 a.m. Eastern Time

• Stifel 2021 Virtual Healthcare Conference
  Date: Monday, November 15^th at 3:20 p.m. Eastern Time

• Jefferies London Healthcare Conference
  Date: Tuesday, November 16^th at 8:40 a.m. Eastern Time

For presentations and fireside chats that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is a clinical-stage biopharmaceutical company with a robust genomic medicines pipeline. Using ground-breaking science, including our proprietary zinc finger genome engineering technology and manufacturing expertise, Sangamo aims to create new genomic medicines for patients suffering from diseases for which existing treatment options are inadequate or currently don’t exist. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005592/en/

Investor Relations & Media Inquiries

Aron Feingold

628.252.7494

afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.

FAQ

What conferences will Sangamo Therapeutics participate in November 2021?

Sangamo Therapeutics will participate in the Barclays Gene Editing & Gene Therapy Summit, the Stifel 2021 Virtual Healthcare Conference, and the Jefferies London Healthcare Conference in November 2021.

When is the Barclays Gene Editing & Gene Therapy Summit?

The Barclays Gene Editing & Gene Therapy Summit is scheduled for November 15, 2021, at 10:30 a.m. Eastern Time.

What is the date and time for Stifel 2021 Virtual Healthcare Conference?

The Stifel 2021 Virtual Healthcare Conference will take place on November 15, 2021, at 3:20 p.m. Eastern Time.

When will Sangamo present at the Jefferies London Healthcare Conference?

Sangamo will present at the Jefferies London Healthcare Conference on November 16, 2021, at 8:40 a.m. Eastern Time.

Where can I watch Sangamo's conference presentations?

Sangamo's conference presentations will be webcast live and accessible via the Investors and Media section on Sangamo's website.